Petros Pharmaceuticals, Inc. (PTPI) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 4.39M | 5.16B | 6.13M | 7.4M | 14.47M | 7.29M | 10.72M | 13.98M | 17.9M | 20.39M | 24.43M | 13.15M |
| Cash & Short-Term Investments | 4.35M | 5.14B | 6.07M | 7.32M | 8.93M | 3.71M | 3.89M | 7.46M | 11.08M | 13.34M | 17.97M | 7.38M |
| Cash Only | 4.35M | 5.14B | 6.07M | 7.32M | 8.93M | 3.71M | 3.89M | 7.46M | 11.08M | 13.34M | 17.97M | 7.38M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 416.08K | 1.95M | 1.78M | 1.96M | 2.23M | 2.98M | 2.58M |
| Days Sales Outstanding | - | - | - | - | - | 149.95 | 108.7 | 119.51 | 137.05 | -656.84 | 152.5 | 113.55 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 3M | 3.05M | 2.85M | 2.74M | 2.79M | 2.5M | 2.18M |
| Days Inventory Outstanding | - | - | - | - | - | 1.05K | 946.01 | 772.47 | 239.85 | 1.54K | 527.16 | 373.47 |
| Other Current Assets | 42K | 26.88M | 63.2K | 75.34K | 5.48M | 6.53K | 1.42M | 1.27M | 1.03M | 816.21K | 751.88K | 715.8K |
| Total Non-Current Assets | 0 | 0 | 0 | 0 | 3.14M | 3.34M | 9.97M | 11.19M | 12.41M | 13.41M | 14.48M | 15.58M |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 136.68K | 143.75K | 177.59K | 216.97K | 255.22K | 292.36K | 328.46K |
| Fixed Asset Turnover | - | - | - | - | - | 5.17x | 9.81x | 7.21x | 5.88x | -1.33x | 5.39x | 5.76x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 3.2M | 6.83M | 7.54M | 8.26M | 8.97M | 9.77M | 10.6M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 3.14M | 0 | 3M | 3.47M | 3.94M | 4.18M | 4.42M | 4.65M |
| Total Assets | 4.39M | 5.16B | 6.13M | 7.4M | 17.61M | 10.64M | 20.69M | 25.17M | 30.31M | 33.8M | 38.91M | 28.73M |
| Asset Turnover | - | - | - | - | - | 0.05x | 0.07x | 0.05x | 0.04x | -0.01x | 0.05x | 0.07x |
| Asset Growth % | -75.04% | 48451.46% | -70.36% | -70.61% | -41.92% | -68.53% | -46.82% | -12.38% | -0.84% | 4.24% | 3.23% | -43.73% |
| Total Current Liabilities | 2.62M | 2.29B | 2.77M | 2.95M | 27.13M | 18.03M | 12.56M | 9.98M | 11.22M | 10.77M | 8.08M | 7.97M |
| Accounts Payable | 133.3K | 83.88K | 421.14K | 970.02K | 756.7K | 2.33M | 1.6M | 791.09K | 2.14M | 1.71M | 1.36M | 1.78M |
| Days Payables Outstanding | - | - | - | - | - | 682.81 | 383.39 | 404.85 | 166.91 | 892.48 | 353.47 | 322.49 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 7.25M | 2.33M | 1.94M | 1.55M | 1.16M | 1.14M | 1.12M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 1.72M | 0 | 0 | 0 | 0 | 0 | 2.05M | 0 | 0 |
| Other Current Liabilities | 2.49M | 2.29B | 2.34M | 234K | 26.18M | 7.1M | 7.39M | 5.52M | 5.77M | 1.03M | 4.42M | 2.71M |
| Current Ratio | 1.68x | 2.25x | 2.22x | 2.51x | 0.53x | 0.40x | 0.85x | 1.40x | 1.60x | 1.89x | 3.02x | 1.65x |
| Quick Ratio | 1.68x | 2.25x | 2.22x | 2.51x | 0.53x | 0.24x | 0.61x | 1.12x | 1.35x | 1.63x | 2.71x | 1.38x |
| Cash Conversion Cycle | - | - | - | - | - | 518.98 | 671.32 | 487.13 | 209.99 | -9.35 | 326.18 | 164.53 |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 57.59K | 75.22K | 5.01M | 6.01M | 8.4M | 10.55M | 23.78M | 7.82M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 4.92M | 5.7M | 6.46M | 6.86M | 7.25M | 7.63M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 75.22K | 91.83K | 107.76K | 123.02K | 137.66K | 151.4K | 183.33K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 57.59K | 0 | 0 | 202K | 1.82M | 3.55M | 16.38M | 1 |
| Total Liabilities | 2.62M | 2.29B | 2.77M | 2.95M | 27.19M | 18.1M | 17.58M | 15.98M | 19.62M | 21.32M | 31.86M | 15.78M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 7.39M | 7.34M | 7.74M | 8.14M | 8.28M | 8.69M | 9.09M |
| Net Debt | -4.35M | -5.14B | -6.07M | -7.32M | -8.93M | 3.68M | 3.45M | 281.87K | -2.94M | -5.06M | -9.28M | 1.71M |
| Debt / Equity | - | - | - | - | - | - | 2.35x | 0.84x | 0.76x | 0.66x | 1.23x | 0.70x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | -54.38x | -12.99x | -4.78x | -16.99x | 3.53x | -33.64x | -17.62x |
| Total Equity | 1.77M | 2.87B | 3.37M | 4.45M | -9.58M | -7.47M | 3.12M | 9.19M | 10.69M | 12.48M | 7.06M | 12.94M |
| Equity Growth % | 118.48% | 38544.25% | 8.05% | -51.59% | -189.63% | -159.84% | -55.83% | -29.03% | -30.78% | -25.28% | -65.9% | -62.17% |
| Book Value per Share | 0.04 | 10.23 | 0.08 | 0.17 | -8.25 | -0.09 | 0.32 | 1.24 | 2.25 | 5.25 | 3.33 | 6.11 |
| Total Shareholders' Equity | 1.77M | 2.87B | 3.37M | 4.45M | -9.58M | -7.47M | 3.12M | 9.19M | 10.69M | 12.48M | 7.06M | 12.94M |
| Common Stock | 4.24K | 4.23M | 4.23K | 4.23K | 205 | 1.05K | 1K | 930 | 688 | 298 | 211 | 211 |
| Retained Earnings | -112.28M | -111.29B | -110.96M | -110.04M | -115.47M | -113.21M | -103.93M | -101.71M | -101.05M | -98.89M | -99.21M | -94.66M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |